Blog Archives

Succesful implementation of Quantum Blue­® Adalimumab and Anti-Adalimumab

Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.

Continue Reading →

BÜHLMANN Posters at UEGW 2023

Discover insightful posters from BÜHLMANN focusing on calprotectin assay standardization, presented at the United European Gastroenterology Week 2023!

Continue Reading →

BÜHLMANN sCAL® turbo 10 Application Notes

Completion of 10 application notes for our new turbidimetric immunoassay: BÜHLMANN sCAL® turbo – a fast, inexpensive and reliable biomarker of inflammation in blood serum!

Continue Reading →

BÜHLMANN Poster from the EuroMedLab 2023

New BÜHLMANN poster about recombinant calprotectin as a promising material to overcome discrepant immunoassays standardizations.

Continue Reading →